$CTRE
CareTrust REIT Inc Stock $ctre

$ctre Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024003863 Filed on February 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$63.07M	$59.73M	$217.8M
YoY Change	24.63%	15.29%	11.03%
Cost Of Revenue	$660.0K	$563.0K	$3.423M
YoY Change	-31.46%	-18.99%	-32.07%
Gross Profit	$62.41M	$59.17M	$214.3M
YoY Change	25.72%	15.76%	12.17%
Gross Profit Margin	98.95%	99.06%	98.43%
Selling, General & Admin	$8.639M	$8.240M	$27.98M
YoY Change	45.41%	42.54%	14.19%
% of Gross Profit	13.84%	13.93%	13.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.46M	$13.26M	$51.26M
YoY Change	9.88%	11.02%	1.74%
% of Gross Profit	21.57%	22.4%	23.91%
Operating Expenses	$22.09M	$21.45M	$79.17M
YoY Change	21.5%	21.14%	5.83%
Operating Profit	$40.32M	$37.72M	$135.2M
YoY Change	28.16%	12.91%	16.25%
Interest Expense	$8.228M	-$6.895M	$40.88M
YoY Change	-16.27%	-28.24%	36.24%
% of Operating Profit	20.41%	-18.28%	30.24%
Other Income/Expense, Net
YoY Change
Pretax Income	$28.75M	$26.29M	$53.72M
YoY Change	49.53%	82.85%	-815.72%
Income Tax
% Of Pretax Income
Net Earnings	$28.75M	$26.16M	$53.74M
YoY Change	49.51%	83.66%	-815.89%
Net Earnings / Revenue	45.58%	43.8%	24.68%
Basic Earnings Per Share	$0.22		$0.50
Diluted Earnings Per Share	$0.22	$0.21	$0.50
COMMON SHARES
Basic Shares Outstanding	130.5M shares	119.1M shares	106.0M shares
Diluted Shares Outstanding	133.2M shares		106.2M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$451.2M	$294.4M	$294.4M
YoY Change	1507.31%	2134.39%	2134.39%
Cash & Equivalents	$451.2M	$294.4M	$294.4M
Short-Term Investments
Other Short-Term Assets	$27.75M	$23.34M	$23.34M
YoY Change	-5.99%	99.63%	99.63%
Inventory
Prepaid Expenses
Receivables	$402.0K	$395.0K	$395.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$479.3M	$318.2M	$318.2M
YoY Change	726.01%	1158.42%	1158.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.853B	$1.747B	$1.747B
YoY Change	20.19%	10.76%	10.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.33M	$19.17M	$19.17M
YoY Change	-27.73%	8.19%	8.19%
Total Long-Term Assets	$1.869B	$1.767B	$1.767B
YoY Change	19.5%	10.73%	10.73%
TOTAL ASSETS
Total Short-Term Assets	$479.3M	$318.2M	$318.2M
Total Long-Term Assets	$1.869B	$1.767B	$1.767B
Total Assets	$2.348B	$2.085B	$2.085B
YoY Change	44.77%	28.63%	28.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$35.28M	$33.99M	$33.99M
YoY Change	45.98%	39.54%	39.54%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$76.47M	$70.52M	$70.52M
YoY Change	46.75%	35.86%	35.86%
LONG-TERM LIABILITIES
Long-Term Debt	$595.9M	$595.6M	$595.6M
YoY Change	-18.35%	-17.22%	-17.22%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$595.9M	$595.6M	$595.6M
YoY Change	-18.35%	-17.22%	-17.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.47M	$70.52M	$70.52M
Total Long-Term Liabilities	$595.9M	$595.6M	$595.6M
Total Liabilities	$672.3M	$666.1M	$668.0M
YoY Change	-14.01%	-13.65%	-13.4%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$2.154B	$1.884B
YoY Change	72.89%	51.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.674B	$1.417B	$1.417B
YoY Change
Total Liabilities & Shareholders Equity	$2.348B	$2.085B	$2.085B
YoY Change	44.77%	28.63%	28.63%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$28.75M	$26.16M	$53.74M
YoY Change	49.51%	83.66%	-815.89%
Depreciation, Depletion And Amortization	$13.46M	$13.26M	$51.26M
YoY Change	9.88%	11.02%	1.74%
Cash From Operating Activities	$48.82M	$42.67M	$154.8M
YoY Change	39.01%	26.45%	7.17%
INVESTING ACTIVITIES
Capital Expenditures	$67.02M	$37.05M	$244.8M
YoY Change	3219.32%	1939.19%	737.99%
Acquisitions
YoY Change
Other Investing Activities	-$56.22M	$1.537M	-$23.06M
YoY Change	-4781.43%	-90.5%	-76.51%
Cash From Investing Activities	-$123.2M	-$35.51M	-$267.8M
YoY Change	14966.14%	-347.34%	110.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$634.4M
YoY Change			1243.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$231.1M	283.8M	$394.3M
YoY Change	-1290.86%	-813.38%	-1761.55%
NET CHANGE
Cash From Operating Activities	$48.82M	42.67M	$154.8M
Cash From Investing Activities	-$123.2M	-35.51M	-$267.8M
Cash From Financing Activities	$231.1M	283.8M	$394.3M
Net Change In Cash	$156.7M	291.0M	$281.3M
YoY Change	952.41%	3398.5%	-4287.43%
FREE CASH FLOW
Cash From Operating Activities	$48.82M	$42.67M	$154.8M
Capital Expenditures	$67.02M	$37.05M	$244.8M
Free Cash Flow	-$18.20M	$5.615M	-$89.99M
YoY Change	-154.97%	-82.41%	-178.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-4267000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	71982000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10832000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	915757000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001590717
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36181
CY2023	dei	Entity Registrant Name EntityRegistrantName	CareTrust REIT, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3999490
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	905 Calle Amanecer
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92673
CY2023	dei	City Area Code CityAreaCode	949
CY2023	dei	Local Phone Number LocalPhoneNumber	542-3130
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	CTRE
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2000000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	130503392	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Costa Mesa, California
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1567119000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1421410000	usd
CY2023Q4	ctre	Real Estate Investments Accrued Interest RealEstateInvestmentsAccruedInterest	1727000	usd
CY2022Q4	ctre	Real Estate Investments Accrued Interest RealEstateInvestmentsAccruedInterest	1320000	usd
CY2023Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	180368000	usd
CY2022Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	156368000	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	15011000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	12291000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	294448000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13178000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	395000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	416000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	23337000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	11690000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4160000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5428000	usd
CY2023Q4	us-gaap	Assets Assets	2084838000	usd
CY2022Q4	us-gaap	Assets Assets	1620781000	usd
CY2023Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	396039000	usd
CY2022Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	395150000	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	199559000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	199348000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	125000000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	33992000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	24360000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	36531000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	27550000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	666121000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	771408000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	129992796	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	129992796	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99010112	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99010112	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1300000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	990000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1883147000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1245337000	usd
CY2023Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	467628000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	396954000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1416819000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	849373000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1898000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1418717000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	849373000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2084838000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1620781000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	198599000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	187506000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	190195000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	19171000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	8626000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	2156000	usd
CY2023	us-gaap	Revenues Revenues	217770000	usd
CY2022	us-gaap	Revenues Revenues	196132000	usd
CY2021	us-gaap	Revenues Revenues	192351000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51199000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50316000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	55340000	usd
CY2023	us-gaap	Interest Expense InterestExpense	40883000	usd
CY2022	us-gaap	Interest Expense InterestExpense	30008000	usd
CY2021	us-gaap	Interest Expense InterestExpense	23677000	usd
CY2023	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	6170000	usd
CY2022	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	4333000	usd
CY2021	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	3574000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	36301000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	79062000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2023	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	3423000	usd
CY2022	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	5039000	usd
CY2021	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	0	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21805000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20165000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26874000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	159781000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	192767000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	109465000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10827000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2218000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-3769000	usd
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-77000	usd
CY2023	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	-6485000	usd
CY2022	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	-7102000	usd
CY2021	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	0	usd
CY2022	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-10871000	usd
CY2021	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-10904000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	53722000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7506000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	71982000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	914142000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22946000	usd
CY2021	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1330000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.06
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	102815000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	71982000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	47236000	usd
CY2022	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-4469000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5758000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.10
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	107403000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7506000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	849373000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	634446000	usd
CY2023	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1479000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5153000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.12
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	124409000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	41000	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1952000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	53722000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1418717000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	53722000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7506000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	71982000	usd
CY2023	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	51257000	usd
CY2022	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	50378000	usd
CY2021	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	55394000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2436000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2095000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2052000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10827000	usd
CY2023	ctre	Unrealized Gain Loss On Other Real Estate Related Investments Operating Cash Flows UnrealizedGainLossOnOtherRealEstateRelatedInvestmentsOperatingCashFlows	-6485000	usd
CY2022	ctre	Unrealized Gain Loss On Other Real Estate Related Investments Operating Cash Flows UnrealizedGainLossOnOtherRealEstateRelatedInvestmentsOperatingCashFlows	-7102000	usd
CY2021	ctre	Unrealized Gain Loss On Other Real Estate Related Investments Operating Cash Flows UnrealizedGainLossOnOtherRealEstateRelatedInvestmentsOperatingCashFlows	0	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5153000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5758000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10832000	usd
CY2023	us-gaap	Straight Line Rent StraightLineRent	-29000	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	17000	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	32000	usd
CY2023	us-gaap	Amortization Of Below Market Lease AmortizationOfBelowMarketLease	384000	usd
CY2022	us-gaap	Amortization Of Below Market Lease AmortizationOfBelowMarketLease	0	usd
CY2021	us-gaap	Amortization Of Below Market Lease AmortizationOfBelowMarketLease	0	usd
CY2023	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
CY2022	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	1417000	usd
CY2021	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	407000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1165000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	155000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2218000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-3769000	usd
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-77000	usd
CY2023	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	36301000	usd
CY2022	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	79062000	usd
CY2021	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-604000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	562000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	21000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-123000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-399000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2423000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1049000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6057000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	154767000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	144415000	usd
CY2023	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	233776000	usd
CY2021	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	6013000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	60319000	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	149650000	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	1253000	usd
CY2023	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	26525000	usd
CY2022	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	6308000	usd
CY2021	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	393000	usd
CY2023	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	3800000	usd
CY2022	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	0	usd
CY2021	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	0	usd
CY2023	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	16313000	usd
CY2022	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	45149000	usd
CY2021	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	6958000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-267815000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127400000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-192633000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	634446000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47236000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22946000	usd
CY2023	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	400000000	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	185000000	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	160000000	usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	220000000	usd
CY2023	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	0	usd
CY2022	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	0	usd
CY2021	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	300000000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	310000000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	115000000	usd
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	190000000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	68000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5361000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	14095000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1479000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4469000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1331000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	115492000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	106138000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	100782000	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1952000	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	41000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	394318000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23732000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36738000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	281270000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6717000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	976000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13178000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19895000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18919000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294448000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13178000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19895000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	40028000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	25912000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	22838000	usd
CY2023	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	8982000	usd
CY2022	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	1265000	usd
CY2021	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	2033000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	369000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	0	usd
CY2022	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	7000	usd
CY2021	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	358000	usd
CY2023	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	2000000	usd
CY2022	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	12000000	usd
CY2021	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	usd
CY2023Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	28	state
CY2023Q4	ctre	Number Of Preferred Equity Investment NumberOfPreferredEquityInvestment	1	investment
CY2023Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	180400000	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	198244000	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	188906000	usd
CY2021	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	190100000	usd
CY2023	us-gaap	Straight Line Rent StraightLineRent	-29000	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	17000	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	32000	usd
CY2023	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	0	usd
CY2022	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	0	usd
CY2023	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	0	usd
CY2022	ctre	Operating Lease Lease Income Adjustments For Recovery OperatingLeaseLeaseIncomeAdjustmentsForRecovery	0	usd
CY2022	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	1400000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.</span></div>
CY2023Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	7300000	usd
CY2023Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	400000	usd
CY2023Q4	ctre	Below Market Lease Weighted Average Remaining Amortization Period BelowMarketLeaseWeightedAverageRemainingAmortizationPeriod	P3Y
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	36300000	usd
CY2022	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	79100000	usd
CY2023Q4	ctre	Number Of Preferred Equity Investment NumberOfPreferredEquityInvestment	1	investment
CY2023	ctre	Operating Lease Lease Income Amortization Of Below Market Lease Intangible OperatingLeaseLeaseIncomeAmortizationOfBelowMarketLeaseIntangible	384000	usd
CY2022	ctre	Operating Lease Lease Income Amortization Of Below Market Lease Intangible OperatingLeaseLeaseIncomeAmortizationOfBelowMarketLeaseIntangible	0	usd
CY2021	ctre	Operating Lease Lease Income Amortization Of Below Market Lease Intangible OperatingLeaseLeaseIncomeAmortizationOfBelowMarketLeaseIntangible	0	usd
CY2023	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
CY2022	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	1417000	usd
CY2021	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	4800000	usd
CY2022Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	2500000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10800000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5200000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5800000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10800000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company is subject to concentrations of credit risk consisting primarily of operating leases on its owned properties. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for a discussion of major operator concentration.</span></div>
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	63000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	198599000	usd
CY2023Q4	us-gaap	Land Land	279276000	usd
CY2022Q4	us-gaap	Land Land	238738000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1620014000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1483133000	usd
CY2023Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	100504000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	97199000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5283000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2832000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2005077000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1821902000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	437958000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	400492000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1567119000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1421410000	usd
CY2023Q4	ctre	Number Of Facilities NumberOfFacilities	226	facility
CY2023Q4	ctre	Number Of Facilities NumberOfFacilities	226	facility
CY2023Q4	ctre	Number Of Facilities NumberOfFacilities	226	facility
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	200650000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	201648000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	200530000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	197378000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	195140000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	970806000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1966152000	usd
CY2023	ctre	Period Of Option Window PeriodOfOptionWindow	P6M
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	187506000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	190195000	usd
CY2023	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	5500000	usd
CY2022	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	2800000	usd
CY2021	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	3600000	usd
CY2022	ctre	Number Of Operators Collection Of Lease Payment Through Maturity Not Probable NumberOfOperatorsCollectionOfLeasePaymentThroughMaturityNotProbable	5	operator
CY2023	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	233775000	usd
CY2023	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	19175000	usd
CY2023	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	15	property
CY2023	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	1665	bed
CY2022	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	21921000	usd
CY2022	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	2050000	usd
CY2022	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	2	property
CY2022	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	265	bed
CY2021	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	196076000	usd
CY2021	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	13103000	usd
CY2021	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	10	property
CY2021	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	1247	bed
CY2023Q4	ctre	Number Of Installments NumberOfInstallments	15	installment
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	36300000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	79100000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q4	ctre	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	190197000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	178568000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	156368000	usd
CY2023Q2	ctre	Number Of Facilities NumberOfFacilities	1	facility
CY2022Q3	ctre	Number Of Facilities Operated By Existing Operator NumberOfFacilitiesOperatedByExistingOperator	4	facility
CY2022Q3	ctre	Number Of Facilities Operated By Large Regional Operator NumberOfFacilitiesOperatedByLargeRegionalOperator	1	facility
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	600000000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4402000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	595598000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	725000000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	5502000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	719498000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2023	ctre	Loan Receivable Origination LoanReceivableOrigination	8486000	usd
CY2022	ctre	Loan Receivable Origination LoanReceivableOrigination	14500000	usd
CY2021	ctre	Loan Receivable Origination LoanReceivableOrigination	1253000	usd
CY2023	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	988000	usd
CY2022	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	6307000	usd
CY2021	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	393000	usd
CY2023	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	-58000	usd
CY2022	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	4000	usd
CY2021	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	6000	usd
CY2023	ctre	Loan Receivable Provision For Loan Losses Net LoanReceivableProvisionForLoanLossesNet	0	usd
CY2022	ctre	Loan Receivable Provision For Loan Losses Net LoanReceivableProvisionForLoanLossesNet	3844000	usd
CY2021	ctre	Loan Receivable Provision For Loan Losses Net LoanReceivableProvisionForLoanLossesNet	0	usd
CY2023	ctre	Loan Receivable Net Change LoanReceivableNetChange	7556000	usd
CY2022	ctre	Loan Receivable Net Change LoanReceivableNetChange	4345000	usd
CY2021	ctre	Loan Receivable Net Change LoanReceivableNetChange	854000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	19171000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	8626000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	2156000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	36300000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	79100000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	200000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	400000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	600000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-04-14
CY2023Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-07-14
CY2023Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-10-13
CY2023Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2024-01-12
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	27846000	usd
CY2023Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	27853000	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	32403000	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	36531000	usd
CY2023Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-03-31
CY2023Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-06-30
CY2023Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-09-29
CY2023Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-12-29
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2022-04-15
CY2022Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2022-07-15
CY2022Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2022-10-14
CY2022Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-01-13
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	26691000	usd
CY2022Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	26683000	usd
CY2022Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	26683000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	27386000	usd
CY2022Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2022-03-31
CY2022Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2022-06-30
CY2022Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2022-09-30
CY2022Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2022-12-30
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.265
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.265
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.265
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.265
CY2021Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2021-04-15
CY2021Q2	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2021-07-15
CY2021Q3	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2021-10-15
CY2021Q4	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2022-01-14
CY2021Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	25633000	usd
CY2021Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	25714000	usd
CY2021Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	25714000	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	25755000	usd
CY2021Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2021-03-31
CY2021Q2	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2021-06-30
CY2021Q3	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2021-09-30
CY2021Q4	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2021-12-31
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	573609	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.63
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	185767	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	20.94
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	68136	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	20.85
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	510596	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	21.01
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5153000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5758000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10832000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	10400000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	53735000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7506000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	71982000	usd
CY2023	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	400000	usd
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	440000	usd
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	507000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	53335000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	53335000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7946000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7946000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	71475000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	71475000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105956000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96703000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96017000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106152000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96703000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96092000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	475000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	744000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	591000	shares
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	350732000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	315914000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	304785000	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Prior Liens1 MortgageLoansOnRealEstatePriorLiens1	1170106000	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	190197000	usd
CY2023Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	0	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	281689000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	1527054000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Improvements RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImprovements	126288000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	279276000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	1620014000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1899290000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	350732000	usd
CY2023Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	1900000000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1721871000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1873806000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1683205000	usd
CY2023	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	233876000	usd
CY2022	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	21252000	usd
CY2021	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	190133000	usd
CY2023	us-gaap	Real Estate Improvements RealEstateImprovements	8878000	usd
CY2022	us-gaap	Real Estate Improvements RealEstateImprovements	5896000	usd
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	4521000	usd
CY2023	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	10078000	usd
CY2022	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	29803000	usd
CY2021	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	usd
CY2023	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	55257000	usd
CY2022	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	149280000	usd
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	4053000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1899290000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1721871000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1873806000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	315914000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	304785000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	259803000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	45275000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	42131000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	45498000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	2076000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	10232000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	8381000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	20770000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	516000	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	178568000	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Federal Income Tax Basis1 MortgageLoansOnRealEstateFederalIncomeTaxBasis1	190200000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	156368000	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	15155000	usd
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	15000000	usd
CY2023	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	53834000	usd
CY2022	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	147150000	usd
CY2021	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	0	usd
CY2023	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	388000	usd
CY2022	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	1165000	usd
CY2021	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	155000	usd
CY2023	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	25537000	usd
CY2022	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2021	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2023	us-gaap	Mortgage Loans On Real Estate Other Deductions MortgageLoansOnRealEstateOtherDeductions	6485000	usd
CY2022	us-gaap	Mortgage Loans On Real Estate Other Deductions MortgageLoansOnRealEstateOtherDeductions	7102000	usd
CY2021	us-gaap	Mortgage Loans On Real Estate Other Deductions MortgageLoansOnRealEstateOtherDeductions	0	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	178568000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	156368000	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	15155000	usd

Files In Submission

Name	View Source	Status
0001628280-24-003863-index-headers.html	Edgar Link	pending
0001628280-24-003863-index.html	Edgar Link	pending
0001628280-24-003863.txt	Edgar Link	pending
0001628280-24-003863-xbrl.zip	Edgar Link	pending
ctre-20231231.htm	Edgar Link	pending
ctre-20231231.xsd	Edgar Link	pending
ctre-20231231_g1.jpg	Edgar Link	pending
ctre-clawbackpolicy.htm	Edgar Link	pending
ctre20231231ex211q4.htm	Edgar Link	pending
ctre20231231ex231q4.htm	Edgar Link	pending
ctre20231231ex311q4.htm	Edgar Link	pending
ctre20231231ex312q4.htm	Edgar Link	pending
ctre-20231231_cal.xml	Edgar Link	unprocessable
ctre-20231231_lab.xml	Edgar Link	unprocessable
ctre-20231231_pre.xml	Edgar Link	unprocessable
ctre-20231231_htm.xml	Edgar Link	completed
ctre20231231ex321q4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ctre-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTRE
CareTrust REIT Inc Stock $ctre

2024 Q1 Form 10-K Financial Statement

#000162828024003863 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE CareTrust REIT Inc Stock $ctre

2024 Q1 Form 10-K Financial Statement

#000162828024003863 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE
CareTrust REIT Inc Stock $ctre